Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria.

Balin SJ, Pellegrini M, Klechevsky E, Won ST, Weiss DI, Choi AW, Hakimian J, Lu J, Ochoa MT, Bloom BR, Lanier LL, Stenger S, Modlin RL.

Sci Immunol. 2018 Aug 31;3(26). pii: eaat7668. doi: 10.1126/sciimmunol.aat7668.

2.

Electrophilic properties of itaconate and derivatives regulate the IκBζ-ATF3 inflammatory axis.

Bambouskova M, Gorvel L, Lampropoulou V, Sergushichev A, Loginicheva E, Johnson K, Korenfeld D, Mathyer ME, Kim H, Huang LH, Duncan D, Bregman H, Keskin A, Santeford A, Apte RS, Sehgal R, Johnson B, Amarasinghe GK, Soares MP, Satoh T, Akira S, Hai T, de Guzman Strong C, Auclair K, Roddy TP, Biller SA, Jovanovic M, Klechevsky E, Stewart KM, Randolph GJ, Artyomov MN.

Nature. 2018 Apr;556(7702):501-504. doi: 10.1038/s41586-018-0052-z. Epub 2018 Apr 18.

3.

A type of human skin dendritic cell marked by CD5 is associated with the development of inflammatory skin disease.

Korenfeld D, Gorvel L, Munk A, Man J, Schaffer A, Tung T, Mann C, Klechevsky E.

JCI Insight. 2017 Sep 21;2(18). pii: 96101. doi: 10.1172/jci.insight.96101. eCollection 2017 Sep 21.

4.

Dendritic Cell-Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function.

Gorvel L, Korenfeld D, Tung T, Klechevsky E.

J Immunol. 2017 Aug 15;199(4):1290-1300. doi: 10.4049/jimmunol.1601477. Epub 2017 Jul 12.

5.

Functional Diversity of Human Dendritic Cells.

Klechevsky E.

Adv Exp Med Biol. 2015;850:43-54. doi: 10.1007/978-3-319-15774-0_4. Review.

PMID:
26324345
6.

Modular expression analysis reveals functional conservation between human Langerhans cells and mouse cross-priming dendritic cells.

Artyomov MN, Munk A, Gorvel L, Korenfeld D, Cella M, Tung T, Klechevsky E.

J Exp Med. 2015 May 4;212(5):743-57. doi: 10.1084/jem.20131675. Epub 2015 Apr 27.

7.

Human dendritic cells - stars in the skin.

Klechevsky E.

Eur J Immunol. 2013 Dec;43(12):3147-55. doi: 10.1002/eji.201343790. Epub 2013 Nov 21. Review.

8.

Human dendritic cells subsets as targets and vectors for therapy.

Klechevsky E, Banchereau J.

Ann N Y Acad Sci. 2013 May;1284:24-30. doi: 10.1111/nyas.12113. Review.

PMID:
23651190
9.

Brucella β 1,2 cyclic glucan is an activator of human and mouse dendritic cells.

Martirosyan A, Pérez-Gutierrez C, Banchereau R, Dutartre H, Lecine P, Dullaers M, Mello M, Salcedo SP, Muller A, Leserman L, Levy Y, Zurawski G, Zurawski S, Moreno E, Moriyón I, Klechevsky E, Banchereau J, Oh S, Gorvel JP.

PLoS Pathog. 2012;8(11):e1002983. doi: 10.1371/journal.ppat.1002983. Epub 2012 Nov 15.

10.

Immunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell priming.

Banchereau J, Zurawski S, Thompson-Snipes L, Blanck JP, Clayton S, Munk A, Cao Y, Wang Z, Khandelwal S, Hu J, McCoy WH 4th, Palucka KA, Reiter Y, Fremont DH, Zurawski G, Colonna M, Shaw AS, Klechevsky E.

Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18885-90. doi: 10.1073/pnas.1205785109. Epub 2012 Oct 29.

11.

Noncovalent assembly of anti-dendritic cell antibodies and antigens for evoking immune responses in vitro and in vivo.

Flamar AL, Zurawski S, Scholz F, Gayet I, Ni L, Li XH, Klechevsky E, Quinn J, Oh S, Kaplan DH, Banchereau J, Zurawski G.

J Immunol. 2012 Sep 1;189(5):2645-55. doi: 10.4049/jimmunol.1102390. Epub 2012 Aug 3.

12.

The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming.

Banchereau J, Thompson-Snipes L, Zurawski S, Blanck JP, Cao Y, Clayton S, Gorvel JP, Zurawski G, Klechevsky E.

Blood. 2012 Jun 14;119(24):5742-9. doi: 10.1182/blood-2011-08-371245. Epub 2012 Apr 25.

13.

Targeting human dendritic cell subsets for improved vaccines.

Ueno H, Klechevsky E, Schmitt N, Ni L, Flamar AL, Zurawski S, Zurawski G, Palucka K, Banchereau J, Oh S.

Semin Immunol. 2011 Feb;23(1):21-7. doi: 10.1016/j.smim.2011.01.004. Epub 2011 Jan 28. Review.

14.

Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.

Klechevsky E, Flamar AL, Cao Y, Blanck JP, Liu M, O'Bar A, Agouna-Deciat O, Klucar P, Thompson-Snipes L, Zurawski S, Reiter Y, Palucka AK, Zurawski G, Banchereau J.

Blood. 2010 Sep 9;116(10):1685-97. doi: 10.1182/blood-2010-01-264960. Epub 2010 Jun 7.

15.

Harnessing human dendritic cell subsets for medicine.

Ueno H, Schmitt N, Klechevsky E, Pedroza-Gonzalez A, Matsui T, Zurawski G, Oh S, Fay J, Pascual V, Banchereau J, Palucka K.

Immunol Rev. 2010 Mar;234(1):199-212. doi: 10.1111/j.0105-2896.2009.00884.x. Review.

16.

Harnessing human dendritic cell subsets to design novel vaccines.

Banchereau J, Klechevsky E, Schmitt N, Morita R, Palucka K, Ueno H.

Ann N Y Acad Sci. 2009 Sep;1174:24-32. doi: 10.1111/j.1749-6632.2009.04999.x. Review.

17.

Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines.

Klechevsky E, Liu M, Morita R, Banchereau R, Thompson-Snipes L, Palucka AK, Ueno H, Banchereau J.

Hum Immunol. 2009 May;70(5):281-8. doi: 10.1016/j.humimm.2009.02.004. Epub 2009 Feb 21.

18.

Influenza virus and poly(I:C) inhibit MHC class I-restricted presentation of cell-associated antigens derived from infected dead cells captured by human dendritic cells.

Frleta D, Yu CI, Klechevsky E, Flamar AL, Zurawski G, Banchereau J, Palucka AK.

J Immunol. 2009 Mar 1;182(5):2766-76. doi: 10.4049/jimmunol.0801720.

19.

Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells.

Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson-Snipes L, Briere F, Chaussabel D, Zurawski G, Palucka AK, Reiter Y, Banchereau J, Ueno H.

Immunity. 2008 Sep 19;29(3):497-510. doi: 10.1016/j.immuni.2008.07.013.

20.

Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts.

Klechevsky E, Gallegos M, Denkberg G, Palucka K, Banchereau J, Cohen C, Reiter Y.

Cancer Res. 2008 Aug 1;68(15):6360-7. doi: 10.1158/0008-5472.CAN-08-0928.

21.

Dendritic cell subsets in health and disease.

Ueno H, Klechevsky E, Morita R, Aspord C, Cao T, Matsui T, Di Pucchio T, Connolly J, Fay JW, Pascual V, Palucka AK, Banchereau J.

Immunol Rev. 2007 Oct;219:118-42. Review.

PMID:
17850486
22.

T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.

Noy R, Eppel M, Haus-Cohen M, Klechevsky E, Mekler O, Michaeli Y, Denkberg G, Reiter Y.

Expert Rev Anticancer Ther. 2005 Jun;5(3):523-36. Review.

PMID:
16250828
23.

Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon.

Banchereau J, Ueno H, Dhodapkar M, Connolly J, Finholt JP, Klechevsky E, Blanck JP, Johnston DA, Palucka AK, Fay J.

J Immunother. 2005 Sep-Oct;28(5):505-16.

PMID:
16113607
24.

Dendritic cells star in Vancouver.

Klechevsky E, Kato H, Sponaas AM.

J Exp Med. 2005 Jul 4;202(1):5-10.

Supplemental Content

Loading ...
Support Center